Organization Profile

Related Organization(s)

You just read:

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis

News provided by

Eli Lilly and Company

Feb 13, 2017, 16:21 ET